InMed Pharmaceuticals

-$0.35 (-10.14%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell INM and other stocks, options, and ETFs commission-free!

About INM

InMed Pharmaceuticals, Inc. engages in the research and development of cannabinoid-based therapies and biosynthesis system for the manufacturing of pharmaceutical-grade cannabinoids. It offers pipeline of medications that target diseases with unmet medical needs, such as epidermolysis bullosa, glaucoma, and orofacial pain.

CEO
Eric A. Adams
Employees
—
Headquarters
Vancouver, British Columbia
Founded
1981

INM Key Statistics

Market Cap
25.12M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
92.87K
High Today
$3.40
Low Today
$3.05
Open Price
$3.40
Volume
79.14K
52 Week High
$10.43
52 Week Low
$2.65

INM Earnings

-$0.37
-$0.25
-$0.12
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected May 21, Pre-Market

You May Also Like

MOON
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure